Morpholino

MO5-pink1

ID
ZDB-MRPHLNO-101007-5
Name
MO5-pink1
Previous Names
  • exon 3 intron 3 (1)
Target
Sequence
5' - TCACAACCTACCCGTTCAAAGTCAG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO5-pink1
Expressed Gene Anatomy Figures
arr3a Fig. 1 from Priyadarshini et al., 2013
atp1a2a Fig. 1 from Priyadarshini et al., 2013
cat Fig. 1 from Priyadarshini et al., 2013
cryaa Fig. 1 from Priyadarshini et al., 2013
dbx1a Fig. 1 from Priyadarshini et al., 2013
fech Fig. 1 from Priyadarshini et al., 2013
fgfr1a Fig. 1 from Priyadarshini et al., 2013
hif1ab Fig. 1 from Priyadarshini et al., 2013
ldb1a Fig. 1 from Priyadarshini et al., 2013
nfe2l3 Fig. 1 from Priyadarshini et al., 2013
notch1a Fig. 2 from Priyadarshini et al., 2013
opn1lw2 Fig. 1 from Priyadarshini et al., 2013
pax2a Fig. 1Fig. 2 from Priyadarshini et al., 2013
pink1 Fig. 2 from Sallinen et al., 2010
shmt1 Fig. 1 from Priyadarshini et al., 2013
slc6a3 Fig. 5 from Sallinen et al., 2010
sod3b Fig. 1 from Priyadarshini et al., 2013
th Fig. 5 with image from Priyadarshini et al., 2013
Fig. 5Fig. 6 from Sallinen et al., 2010
th2 Fig. 5 with image from Priyadarshini et al., 2013
Fig. 5 from Sallinen et al., 2010
vegfaa Fig. 2Fig. 3 from Priyadarshini et al., 2013
vegfba Fig. 2Fig. 3 from Priyadarshini et al., 2013
vegfc Fig. 2Fig. 3 from Priyadarshini et al., 2013
Phenotype
Phenotype resulting from MO5-pink1
Phenotype of all Fish created by or utilizing MO5-pink1
Phenotype Fish Conditions Figures
heart contraction decreased process quality, abnormal WT + MO5-pink1 standard conditions Fig. 4 from Priyadarshini et al., 2013
catalase activity decreased process quality, abnormal WT + MO5-pink1 standard conditions Fig. 4 from Priyadarshini et al., 2013
regulation of reactive oxygen species metabolic process disrupted, abnormal WT + MO5-pink1 standard conditions Fig. 4 from Priyadarshini et al., 2013
vascular endothelial growth factor signaling pathway cellular spatiotemporal quality, abnormal WT + MO5-pink1 standard conditions Fig. 2 from Priyadarshini et al., 2013
nucleate erythrocyte increased amount, abnormal WT + MO5-pink1 chemical treatment: N-acetyl-L-cysteine Fig. 5 from Priyadarshini et al., 2013
regulation of hypoxia-inducible factor-1alpha signaling pathway disrupted, abnormal WT + MO5-pink1 standard conditions Fig. 1 from Priyadarshini et al., 2013
regulation of superoxide dismutase activity disrupted, abnormal WT + MO5-pink1 standard conditions Fig. 1 from Priyadarshini et al., 2013
nucleate erythrocyte increased amount, abnormal WT + MO5-pink1 standard conditions Fig. 5 from Priyadarshini et al., 2013
brain proliferative region increased size, abnormal WT + MO5-pink1 standard conditions Fig. 2 from Priyadarshini et al., 2013
diencephalon dopaminergic neuron decreased amount, abnormal WT + MO5-pink1 standard conditions Fig. 4Fig. 5Fig. 6 from Sallinen et al., 2010
pretectum dopaminergic neuron decreased amount, abnormal WT + MO5-pink1 standard conditions Fig. 6 from Sallinen et al., 2010
Citations